Phenazopyridine Hydrochloride
Product Images NDC 70795-1252

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Phenazopyridine Hydrochloride (NDC 70795-1252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Graxcell Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_1 (01b Lbl Phenazopyridine HCl 100mg Insert Page 1)

Text panel for Phenazopyridine Hydrochloride Tablets by Graxcell Pharmaceuticals LLC, including a disclaimer about FDA approval status, prescription warning, a brief description of the drug's physical properties and effect, and a depiction of the chemical structure with molecular formula and weight.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_2 (01b Lbl Phenazopyridine HCl 100mg Insert Page 2)

This text panel for Phenazopyridine Hydrochloride tablets details the inactive ingredients, pharmacology, indications, and usage guidelines. It explains Phenazopyridine's topical analgesic effect in the urinary tract, symptom relief uses including pain and urgency, and cautions on treatment duration and appropriate use alongside antibacterial therapy.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_3 (01b Lbl Phenazopyridine HCl 100mg Insert Page 3)

A drug facts text panel for Phenazopyridine Hydrochloride 200 mg detailing contraindications, adverse reactions, precautions, and notes. It includes warnings on hypersensitivity, renal insufficiency, and possible side effects such as headache and rash. The panel also notes potential urine discoloration, laboratory test interactions, and carcinogenesis data from animal studies.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_4 (01b Lbl Phenazopyridine HCl 100mg Insert Page 4)

This text panel provides detailed information on pregnancy category B status, nursing mothers, dosage and administration guidelines for 100 mg and 200 mg Phenazopyridine HCl tablets, and overdose warnings including symptoms and recommended treatments. It addresses reproduction studies in animals, lack of data in pregnant women, dosing limits when combined with antibacterial agents, and potential toxic reactions and complications from overdose.*

FDA Label Image

01b Lbl_phenazopyridine HCl 100mg_insert_page_5 (01b Lbl Phenazopyridine HCl 100mg Insert Page 5)

This text panel describes how Phenazopyridine Hydrochloride tablets are supplied. It details two tablet strengths: 100 mg and 200 mg, each supplied in bottles of 100 tablets. The 100 mg tablets are deep brown to maroon, round, film-coated, and debossed with "G-15" on one side. The 200 mg tablets share the same color and shape but are debossed with "G-17". It also includes storage conditions and manufacturer information for Graxcell Pharmaceuticals LLC.*

FDA Label Image

01b Lbl_phenazopyridine HCl 200mg_100 Ct_front (01b Lbl Phenazopyridine HCl 200mg 100 Ct Front)

Label for Phenazopyridine Hydrochloride 200 mg oral tablets by GRAXCELL PHARMACEUTICAL, LLC. The label states it contains 100 tablets for Rx only. It includes the barcode and manufacturer and distributor addresses in Bohemia, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.